Obesity and aging are usually discussed as separate health issues. Increasingly, though, researchers are finding that they may affect some of the same systems inside the body, from chronic inflammation to the way cells produce energy and repair damage.
A review published in Genes & Diseases examines evidence linking obesity with biological processes associated with aging and considers whether weight loss treatments might influence some of those changes. The paper synthesizes previous research rather than reporting a new clinical trial, and it does not show that obesity directly accelerates aging, shortens lifespan or that losing weight reverses biological age.
Instead, the authors argue that excess body fat can contribute to several of the same types of cellular and metabolic stress that become more common with age.
One of the clearest overlaps involves chronic inflammation.
Fat tissue is biologically active, and excess adipose tissue can release signaling molecules that contribute to persistent, low-grade inflammation throughout the body. That inflammation has been linked with insulin resistance, metabolic dysfunction and cardiovascular disease.
A similar pattern of chronic inflammation can develop with age, sometimes referred to as “inflammaging.” The review argues that this overlap may help explain why obesity is associated with many conditions that also become more common later in life.
The similarities extend beyond inflammation.
The authors describe evidence connecting obesity with changes in mitochondrial function, the process cells use to produce energy, as well as oxidative stress, cellular senescence and disruptions in the body’s ability to maintain and repair tissues.
Researchers have also reported associations between obesity and changes in telomeres, which protect the ends of chromosomes, as well as epigenetic patterns sometimes used to estimate biological age.
Those markers require careful interpretation. A change in a telomere, inflammatory marker or biological-age estimate is not the same as showing that someone is aging faster in every meaningful sense. Biological aging is complex, and researchers do not have a single universally accepted measure that captures it.
The review also examines whether improving metabolic health might influence some of these aging-related markers.
Research cited by the authors suggests that exercise, calorie restriction, bariatric surgery and weight loss can improve several measures associated with metabolic health and cellular stress. The review also discusses anti-obesity medications including liraglutide, semaglutide and tirzepatide.
Some studies have found that these treatments reduce inflammation, improve metabolic function or affect other biological processes associated with aging.
That does not mean anti-obesity medications have been shown to slow human aging or extend lifespan.
Their established benefits come primarily from effects such as weight loss, improved blood sugar control and reductions in cardiovascular risk for certain patients. Whether those changes translate into slower biological aging or longer healthy lifespan remains a separate research question.
The distinction is important because obesity and aging may share biology without being interchangeable conditions.
A person with obesity should not be thought of as simply being “older” biologically, and improving a biomarker associated with aging does not necessarily mean the aging process itself has been reversed.
What the research does suggest is that metabolic health, inflammation and the body's ability to maintain healthy cells may become increasingly interconnected over time.
Understanding those connections could eventually help researchers determine whether treatments aimed at obesity and metabolic disease have benefits that extend beyond weight itself. For now, however, the evidence is stronger for shared biological pathways than for the idea that weight loss can turn back the biological clock.
The review was supported by the National Natural Science Foundation of China.